Allergan Says Teva Bears Sole Liability for Actavis' Actions | Ctech
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Aims to Improve Its Position with Actavis Generics Acquisition
Teva Completes Acquisition of Actavis Generics | Business Wire
Teva acquires Allergan's generics operations in $38.8bn deal - PMLiVE
Teva unclear on which generics affected by Actavis buyout :: C+D
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed | Nasdaq
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
Teva to sell Actavis assets to Accord Healthcare
Teva buys Allergan generic drug business for $40.5B | CBC News
Intas buys Actavis assets in UK, Ireland for Rs 5,100cr - Times of India
Teva completes $40 billion acquisition of Actavis Generics | Pharmafile
Teva Announces Share Pricing Pending Actavis Generics Acquisition
Teva starts post-Actavis cost squeeze, will eliminate 210 jobs in Malta | Fierce Pharma
Teva Completes Acquisition of Actavis Generics - Drug Discovery and Development
Teva's long-acting schizophrenia drug rejected by FDA -
Learning by Example: Teva Pharmaceuticals' Acquisition of Actavis Generics
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher | The Motley Fool
About Teva Generics Who We Are The Teva Advantage Products Product Search New Teva Generics Therapeutic Categories Barcodes Standard Business Terms Return Goods Policy Teva's Authorized Distributors Patients Frequently Asked Questions ...
Teva completes acquisition of Actavis Generics - Globes
Temasek-backed Intas to buy Teva's operations under Actavis in UK & Ireland for $769 mn | VCCircle
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
